H
Hrangdanglien
About Hrangdanglien
Data last updated:
Hrangdanglien is a Director at Zenzi Pharmaceutical Industries Private Limited (since 2019), Director at Alpha-Pharma Healthcare Private Limited (since 2019) and Director at Meghdoot Chemicals Limited (since 2019), and holds 2 more current directorships. The companies operate in Pharma and Chemicals. The 5 current companies with reported revenue have a combined latest revenue of ₹48.51 Cr; the largest is Zenzi Pharmaceutical Industries Private Limited at ₹26.29 Cr (FY 2025). Earlier, Hrangdanglien was an Additional Director at Moirae Generics Private Limited (2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 May 2019 | 2005 | ₹26.29 Cr (FY 2025) | Active | |
| Director | 27 May 2019 | 2014 | ₹20.96 Cr (FY 2025) | Active | |
| Director | 22 May 2019 | 1970 | ₹1.26 Cr (FY 2025) | Active | |
| Director | 22 May 2019 | 2013 | ₹7,130 (FY 2025) | Active | |
| Director | 22 May 2019 | 2012 | ₹5,000 (FY 2016) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 22 May 2019 | 2010 | ₹51,235 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hrangdanglien
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jacob Sporon Fiedler | 01660842 | Zenzi Pharmaceutical Industries Private Limited , Alpha-Pharma Healthcare Private Limited and 3 more | Director |
| Pratik Harshad Kalsariya | 07840355 | Meghdoot Chemicals Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hrangdanglien
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hrangdanglien
Hrangdanglien currently holds 5 directorships: Zenzi Pharmaceutical Industries Private Limited (Director, since 22 May 2019, revenue ₹26.29 Cr (FY 2025)); Alpha-Pharma Healthcare Private Limited (Director, since 27 May 2019, revenue ₹20.96 Cr (FY 2025)); Meghdoot Chemicals Limited (Director, since 22 May 2019, revenue ₹1.26 Cr (FY 2025)); Unigen Life Sciences Private Limited (Director, since 22 May 2019, revenue ₹7,130 (FY 2025)); Coin Pharmaceuticals Private Limited (Director, since 22 May 2019, revenue ₹5,000 (FY 2016)).
Hrangdanglien was first appointed on 22 May 2019 as Director at Zenzi Pharmaceutical Industries Private Limited.
The 5 current companies of Hrangdanglien that report revenue have a combined latest revenue of ₹48.51 Cr: Zenzi Pharmaceutical Industries Private Limited ₹26.29 Cr (FY 2025); Alpha-Pharma Healthcare Private Limited ₹20.96 Cr (FY 2025); Meghdoot Chemicals Limited ₹1.26 Cr (FY 2025); Unigen Life Sciences Private Limited ₹7,130 (FY 2025); Coin Pharmaceuticals Private Limited ₹5,000 (FY 2016).
Hrangdanglien held 1 earlier board appointment: Moirae Generics Private Limited (Additional Director, 22 May 2019 to 16 Sep 2019).
The current boards of Hrangdanglien's companies include Jacob Sporon Fiedler (Zenzi Pharmaceutical Industries Private Limited), Pratik Harshad Kalsariya (Meghdoot Chemicals Limited).